Home > Offer to Sell > Pharmaceuticals and Biochemicals > Others > Hot Sale and best quality Peptide Eptifibatide CAS: 148031-34-9
Hot Sale and best quality Peptide Eptifibatide CAS: 148031-34-9
Inquiry
Post Date: | Jan 20,2017 |
Expiry Date: | Jul 19,2017 |
Detailed Description: |
Cas No. :148031-34-9
Quantity: 1000Kilograms Specs:99% Price:1 USD Kilograms Payment Method: Within 24 hours after we confirm the payment Hot Sale and best quality Peptide Eptifibatide CAS: 148031-34-9 Any problems, please feel free to contact me: Email:jasmine@ycgmp.com whatsapp:+8618872220697 Basic Info Product Name:Eptifibatide Cas No:148031-34-9 MF:C35H49N11O9S2 MT:832.4 Sequence:Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2 Appearance:White slightly yellwish powder Specific Rotation[20/D]:-75.0~-95.0°(C=1,1%HAc) ? Amino Acids composition :± 10% Impurity (%):≤ 1.0% Water Content (Karl Fischer) :≤8.0% Peptide Content(N determination):≥80% Acetate Content :≤15% IR spectrum :in accordance Peptide Purity :≥98% by area integration Related Substance :Total Impurities (%)≤2.0%? Largest Single Brief introduction: Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.[1] Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the so-called arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market. Application: Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevation (e.g., non-Q-wave) myocardial infarction (i.e., non-ST-segment elevation acute coronary syndromes) both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary intervention (PCI). The drug is usually applied together with aspirin or clopidogrel and (low molecular weight or unfractionated) heparin. Additionally, the usual supportive treatment consisting of applications of nitrates, beta-blockers, opioid analgesics and/or benzodiazepines should be employed as indicated. Angiographic evaluation and other intensive diagnostic procedures may be considered a first line task before initiating therapy with eptifibatide. The drug should exclusively be used in hospitalized patients both because of the serious degree of patients' illness and because of the possible side-effects of eptifibatide. Services: 1. Any Inquiries will be replied within 24 hours 2.Hight quality, fashion designs reasonable & competitive price. fast lead time. 3.Payment: You can pay for the order via: T/T, Western Union, MoneyGram&Bitcion 4. After Sale Service: 1).All products will have been strictly Quality Checked in house before packing. 2).All products will be well packed before shipping. 3)Parcel can be sent out in 24 hours after payment. Tracking number available 4)Secure and discreet shipment. Various transportation methods for your choice. 5)Customs pass rate ≥99% 6) We have our own agent/remailer/distributor who can help us ship our products very fast and safe, and we have stock in there for transferring. 5. Shipping we have strong cooperation with DHL, UPS, FEDEX, EMS, China Air PostYou also can choose your own shipping forwarder. |
CAS Registry Number: | 148031-34-9 |
Synonyms: | ;[3-carbamoyl-11-{4-[(diaminomethylidene)amino]butyl}-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid;[(1S,4R,12S,18S,21S)-12-(4-carbamimidamidobutyl)-4-carbamoyl-21-(1H-indol-3-ylmethyl)-2,10,13,16,19,22-hexaoxo-6,7-dithia-3,11,14,17,20,26-hexaazabicyclo[21.2.1]hexacos-18-yl]acetic acid;MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;[(3R,11S,17S,20S,25aS)-11-(4-carbamimidamidobutyl)-3-carbamoyl-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid;Eptifibatide Acetate; |
Molecular Formula: | C35H49N11O9S2 |
Molecular Weight: | 831.96 |
Molecular Structure: |
Company: | Wuhan Yuancheng Gongchuang Technology Co., Ltd [ China ] |
Contact: | Ann |
Tel: | 8618872220697 |
Fax: | 8618872220697 |
Email: | jasmine@ycgmp.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.